title: Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus.
abstract: Equine arteritis virus (EAV) is the causative agent of the equine viral arteritis. It is a small RNA virus with a linear, non-segmented plus RNA genome. EAV is a member of the Arteriviridae family that includes porcine reproductive and respiratory syndrome virus (PRSSV), simian haemorrhagic fever virus (SHFV) and lactate dehydrogenase virus (LDV). The viral transmission is via respiratory and reproductive routes. Clinical signs in horses vary, and severe infection can lead to abortions in pregnant mares or neonatal foal death. The aim of this study was to investigate the development of the immune response in horses after immunization with a DNA vaccine harbouring and expressing EAV Open Reading Frames (ORF) 2, 5, and 7, in combination with equine interleukin 2 (eqIL2). Three boosters followed the basic immunization in two-week intervals. Each immunization was a combination of gene gun and intramuscular injection. All horses developed a high titer of neutralizing antibodies after basic immunization within 2 weeks. Remarkably, this immune response was found to be independent of the age of animals. The youngest horse was six-years old, and the oldest twenty-two years old. A remarkable difference in the immune response between the young and old were not observed. The duration of immunity was investigated during a period of one year. After 12 months, neutralizing antibodies were still detectable in all the vaccinated horses.
authors.affiliation: Boehringer Ingelheim Animal Health, Ingelheim am Rhein, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Giese
authors.forename: U
authors.initials: U
authors.lastname: Bahr
authors.forename: N J
authors.initials: NJ
authors.lastname: Jakob
authors.forename: R
authors.initials: R
authors.lastname: Kehm
authors.forename: M
authors.initials: M
authors.lastname: Handermann
authors.forename: H
authors.initials: H
authors.lastname: Müller
authors.forename: T H
authors.initials: TH
authors.lastname: Vahlenkamp
authors.forename: C
authors.initials: C
authors.lastname: Spiess
authors.forename: T H
authors.initials: TH
authors.lastname: Schneider
authors.forename: G
authors.initials: G
authors.lastname: Schusse
authors.forename: G
authors.initials: G
authors.lastname: Darai
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D018174:Arterivirus Infections / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D007240:Equartevirus / Q000276:immunology*; D006734:Horse Diseases / Q000517:prevention & control* / Q000821:virology; D006736:Horses; D007376:Interleukin-2 / Q000235:genetics / Q000276:immunology; D009500:Neutralization Tests; D016366:Open Reading Frames / Q000235:genetics / Q000276:immunology; D010957:Plasmids; D014611:Vaccination; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007376:Interleukin-2; D019444:Vaccines, DNA; D014765:Viral Vaccines